C12Y 305/01098
Histone deacetylase , i.e. sirtuin deacetylase
Official title: Histone deacetylase (3.5.1.98), i.e. sirtuin deacetylase
C12Y305/01098 (Histone deacetylase , i.e. sirtuin deacetylase) appears on 48 US grants and 110 published applications in this corpus.
Search patents in C12Y- Granted patents
- 48
- Published applications
- 110
- Assignees
- 72
- Inventors
- 233
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 7 |
| 2012 | 0 | 4 |
| 2013 | 3 | 2 |
| 2014 | 2 | 5 |
| 2015 | 3 | 7 |
| 2016 | 2 | 5 |
| 2017 | 1 | 7 |
| 2018 | 4 | 9 |
| 2019 | 4 | 9 |
| 2020 | 4 | 10 |
| 2021 | 5 | 4 |
| 2022 | 5 | 6 |
| 2023 | 4 | 9 |
| 2024 | 3 | 9 |
| 2025 | 1 | 5 |
| 2026 | 5 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of treating age-related retinal dysfunction18 Aug 2026US 12,708,616 B2The Regents of the University of California
- Methods and compositions for rejuvenating CNS glial populations by suppresion of transcription factors21 Jul 2026US 12,686,868 B2University of Rochester
- MicroRNA-mediated methods for rejuvenating CNS glial populations3 Mar 2026US 12,565,648 B2University of Rochester
- Methods for the design of nonallosteric sirtuin activating compounds3 Mar 2026US 12,565,673 B2Chakrabarti Advanced Technology LLC
- Methods and compositions for modulating gene expression13 Jan 2026US 12,522,823 B2Flagship Pioneering Innovations V, Inc.
- Methods and compositions for modulating gene expression6 Aug 2026US 2026/0226464 A1Flagship Pioneering Innovations V, Inc.
- Engineered CasPhi2 Nucleases28 May 2026US 2026/0146241 A1
- Methods and compositions for cancer therapy12 Mar 2026US 2026/0069581 A1
- Crystalline forms12 Mar 2026US 2026/0070895 A1Quimatryx, S.L.
- Use of conjugates of microrna and cardiac targeting peptides for treating heart failure13 Nov 2025US 2025/0346903 A1Georgetown University
Most cited
By later US patents
- Engineered CRISPR-Cas9 nucleases50US 9,926,546 B2The General Hospital Corporation · 2018
- Engineered CRISPR-Cas9 nucleases15US 10,526,591 B2The General Hospital Corporation · 2020
- Methods and compositions for regulating HDAC4 activity8US 7,737,175 B2Duke University · 2010
- Methods and compositions for modulating gene expression6US 11,312,955 B2Flagship Pioneering Innovations V, Inc. · 2022
- Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain4US 7,863,414 B2Board of Regents, The University of Texas Systems · 2011